{"name":"Ahmed A. H. Abdellatif","slug":"ahmed-a-h-abdellatif","ticker":"","exchange":"","domain":"","description":"Ahmed A. H. Abdellatif is a pharmaceutical company focused on developing innovative treatments across various therapeutic areas. The company has a pipeline of 7 drugs, with several in early-stage clinical trials and one marketed product.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Cream Base","genericName":"Cream Base","slug":"cream-base","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Cream Base","genericName":"Cream Base","slug":"cream-base","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE0yRXRubjRoT3V0aVptdFJCNWx4TVJMZjJzTzJlTzgydHIyTkRZb1RtbFVvSkN4eUNTNEJKdk5VYnJURFZZOFljQmxNWUt1U0xCWlRwMF92emVHaHIyZnRPYQ?oc=5","date":"2025-09-18","type":"pipeline","source":"Science | AAAS","summary":"Global implications of cholera in Sudan - Science | AAAS","headline":"Global implications of cholera in Sudan - Science | AAAS","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxON1lQRjJnRmYxbE9CeGZidklJMW01V0kxVmdEeGUwak9LRFR6RTlRLVI0OHNVM1pXakRJSmo5RHBjbUJFZWNjNU0xbzBvZ1pUaTIzSVF4NERaSDdFWFZxbXJHT2NmQ1V5dUFncjRKc0NJVi1tcnRfUXBTX0dnMTZKeTVMLVFfTHhwRlk5b0hrQkhjUHdBN3RrNzF2VEdrWjhpMWRIZFFSR1hLVng0RFBpclBBVkFBb2FWTkRoUkh6cEF2ZGRpS2FlWnZWUQ?oc=5","date":"2022-05-02","type":"pipeline","source":"Dove Medical Press","summary":"IJN - Dove Medical Press","headline":"IJN","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5oUGVJdGxEcTJVVGQxcU9ocHhYdUdoMzF2TXc4S0k5Z0xOeEpIUVZDeWNNb0tiaE1hd2JTTV83STMyYUZpZ1ZBdFRUcEwwSzJuNGJxcGxpZ09jOGtDSW5V?oc=5","date":"2021-01-08","type":"pipeline","source":"Nature","summary":"Different cellulosic polymers for synthesizing silver nanoparticles with antioxidant and antibacterial activities - Nature","headline":"Different cellulosic polymers for synthesizing silver nanoparticles with antioxidant and antibacterial activities","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}